darbepoetin-alfa (Aranesp)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Aranesp. (a longer acting erythropoietin)

Indications

Contraindications

Dosage

  • Weekly injection

Adverse effects

Notes

Manufacturer: Amgen

More general terms

Additional terms

References

  1. Prescriber's Letter 8(11):61 2001
  2. Department of Veterans Affairs, VA National Formulary
  3. 3.0 3.1 FDA Medwatch http://www.fda.gov/medwatch/safety/2005/safety05.htm#aranesp2 http://www.fda.gov/medwatch/safety/2006/safety06.htm#erythropoiesis
  4. 4.0 4.1 Prescriber's Letter 14(1): 2007 Erythropoiesis Stimulating Agents (Aranesp, Epogen, and Procrit): Caution not to Exceed Recommended Hemoglobin Targets Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230105&pb=PRL (subscription needed) http://www.prescribersletter.com
  5. 5.0 5.1 FDA MedWatch http://www.fda.gov/medwatch/safety/2008/safety08.htm#ESA2
  6. 6.0 6.1 Tonelli M et al. Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: A meta-analysis. CMAJ 2009 May 26; 180:E62. http://dx.doi.org/10.1503/cmaj.090470 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19407261
  7. 7.0 7.1 7.2 Pfeffer MA et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009 Oct 30 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19880844 <Internet> http://dx.doi.org/10.1056/NEJMoa0907845 http://content.nejm.org/cgi/content/abstract/NEJMoa0907845v1
  8. Prescriber's Letter 17(4): 2010 ESA APPRISE Oncology Program for Cancer Patients Using Procrit, Epogen, or Aranesp COMMENTARY: ESA APPRISE Oncology Program for Cancer Patients Using Procrit, Epogen, or Aranesp CHART: Drugs with Special Prescribing and Dispensing Requirements Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260422&pb=PRL (subscription needed) http://www.prescribersletter.com
  9. 9.0 9.1 9.2 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, American College of Physicians, Philadelphia 2015, 2018.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  10. Palmer SC, Saglimbene V, Craig JC et al Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2014 Mar 31;(3):CD009297. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24683046